Lung cancer is primary cancer threatening human life worldwide with the highest mortality
rate. The early detection of lung cancer plays a critical role in the early diagnosis and …

Biomarkers are naturally-occurring characteristics by which a particular pathological process
or disease can be identified or monitored. They can reflect past environmental exposures …

Liquid biopsy is an emerging technology with a potential role in the screening and early
detection of lung cancer. Several liquid biopsy-derived biomarkers have been identified and …

Lung carcinoma is one of the most common human cancers and is estimated to have an
incidence of approximately 2 million new cases per year worldwide with a 20% mortality …

Liquid biopsy, a minimally invasive approach, is a highly powerful clinical tool for the real‐
time follow‐up of cancer and overcomes many limitations of tissue biopsies. Epigenetic …

Lung cancer remains the number one cause of cancer-related deaths worldwide with
221,200 estimated new cases and 158,040 estimated deaths in 2015. Approximately 80% of …

Currently, early detection of lung cancer relies on the characterisation of images generated
from computed tomography (CT). However, lung tissue biopsy, a highly invasive surgical …

Lung cancer is the leading cause of cancer-related deaths worldwide. The initiation and
progression of lung cancer is the result of the interaction between permanent genetic and …

The adverse effects of excessive use of artificial light at night (ALAN) are becoming
increasingly evident and associated with several health problems including cancer. Results …

Background Newly established blood DNA methylation markers that are strongly associated
with smoking might open new avenues for lung cancer (LC) screening. We aimed to assess …